Quick Summary
Obeda 2mg FlexTouch
Last updated on 05 Oct 2026 | 08:53 AM (IST)
₹3733
MRP: ₹4200
(You Save ₹467)
1 PREFILLED PEN(s) OF 1.5ML
Obeda 2mg FlexTouch
Salt Composition
SEMAGLUTIDEMarketer
DR REDDY'S LABORATORIES LTD
Prepaid Only. Non-Returnable.
11% OFF
₹3733
MRP: ₹4,200.00
Inclusive of all taxes
11% Off
Salt Composition
SEMAGLUTIDEMarketer
DR REDDY'S LABORATORIES LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Semabrex 2mg Injection
NATCO PHARMA LT...
₹ 195.50/injection
79% cheaper
Semanat 2mg Injection
NATCO PHARMA LT...
₹ 195.50/injection
79% cheaper
Semafull 2mg Injection
NATCO PHARMA LT...
₹ 195.50/injection
79% cheaper
Sundae 2mg Injection Vial
ERIS LIFESCIENC...
₹ 196.33/injection
78% cheaper
Better Service Satisfied Customers
Introduction
Obeda 2mg FlexTouch contains Semaglutide 2mg in 1.5mL and is supplied as a prefilled pen. This presentation is used to deliver 0.25mg or 0.5mg doses of Semaglutide. Current Indian product information lists Obeda for type 2 diabetes and chronic weight management.
Uses of Obeda 2mg FlexTouch
Obeda 2mg FlexTouch is used for:
Type 2 diabetes mellitus: To improve blood sugar control in adults along with diet and exercise.
Chronic weight management: Semaglutide may be prescribed as part of a reduced-calorie diet and increased physical activity in appropriate adults.
How Obeda 2mg FlexTouch Works
Obeda contains Semaglutide, which activates GLP-1 receptors involved in blood sugar and appetite regulation.
It increases insulin release when blood sugar is high, reduces glucagon release and slows stomach emptying. These effects can improve blood sugar control and reduce hunger and food intake.
Interaction of Obeda 2mg FlexTouch with Other Medicines
Tell your doctor about all medicines, supplements and herbal products you take.
Insulin or sulfonylureas: Can increase the risk of low blood sugar.
Oral medicines: Delayed stomach emptying may affect absorption of some oral medicines.
Other GLP-1 receptor agonists: Do not combine Obeda with another Semaglutide-containing medicine or GLP-1 receptor agonist unless prescribed.
Medicines requiring monitoring: Tell your doctor about medicines that require regular monitoring.
Storage Conditions
Store Obeda 2mg FlexTouch at 2°C to 8°C.
Do not freeze.
Do not use if frozen.
Protect from light.
Keep out of reach of children.
Follow the pack instructions after first use.
How to Use
Use Obeda 2mg FlexTouch exactly as prescribed.
The 2mg/1.5mL presentation delivers 0.25mg or 0.5mg doses. It is injected under the skin once weekly into the abdomen, thigh or upper arm.
The 0.25mg dose is generally used when starting Semaglutide treatment. Your doctor will decide when to increase the dose.
Safety Advice
Pregnancy
Do not use Obeda during pregnancy. Semaglutide should generally be stopped at least 2 months before a planned pregnancy.
Breast Feeding
Do not use Obeda during breastfeeding. Tell your doctor if you are breastfeeding.
Lungs
Tell your doctor before surgery or deep sedation because delayed stomach emptying may increase aspiration risk.
Liver
Tell your doctor if you have liver disease before treatment.
Alcohol
Alcohol may worsen nausea and vomiting and may affect blood sugar control.
Driving
Low blood sugar may affect concentration, particularly when Obeda is used with insulin or sulfonylureas.
Side Effects
Common side effects include
Nausea
vomiting
diarrhoea
constipation
abdominal pain
decreased appetite
headache
dizziness.
Serious side effects:
Severe or persistent abdominal pain
Severe allergic reactions
Persistent vomiting or diarrhoea with dehydration
Gallstones or gallbladder inflammation
Sudden or worsening changes in vision
Low blood sugar when used with insulin or sulfonylureas
Seek medical attention if severe or persistent symptoms occur.
Expert Tips
The 2mg on the pen is the total Semaglutide content.
The pen is used to deliver 0.25mg or 0.5mg doses.
Use Obeda on the same day each week.
Do not increase the dose without medical advice.
Rotate injection sites.
Stay hydrated if vomiting or diarrhoea occurs.
Monitor blood sugar if Obeda is prescribed for diabetes.
Do not share the pen or needles.
FAQs
Q1.
What is Obeda 2mg FlexTouch used for?
Obeda 2mg FlexTouch contains Semaglutide and is used for type 2 diabetes and chronic weight management when prescribed for these indications.
Q2.
How often should I use Obeda 2mg?
It is generally injected once weekly.
Q3.
Can Obeda 2mg cause low blood sugar?
The risk is low when Semaglutide is used alone, but it increases when used with insulin or sulfonylureas.
Q4.
Can Obeda 2mg be used for weight management?
Yes. Semaglutide may be prescribed for chronic weight management in appropriate adults.
Q5.
What should I do if I miss Obeda 2mg?
Follow your doctor's missed-dose instructions. Do not take an extra dose to make up for the missed injection.
Q6.
Can I use Obeda 2mg during pregnancy?
No. Semaglutide should not be used during pregnancy and should generally be stopped at least 2 months before a planned pregnancy.
Fact Box
Molecule name: | Semaglutide |
Therapeutic class: | Antidiabetic / weight management medicine |
Pharmacological class: | GLP-1 receptor agonist |
Indications: | Type 2 diabetes mellitus; chronic weight management |
References
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Vishishta
M.Sc Microbiology
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 05 Oct 2026 | 08:53 AM (IST)
Want to know more?
Read Our Editorial Policy
